Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Adenocarcinoma × atezolizumab × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 54 Neoplasms 28 Small Cell Lung Carcinoma 23 Melanoma 21 Colorectal Neoplasms 20 Carcinoma, Hepatocellular 20 Carcinoma, Transitional Cell 18 Triple Negative Breast Neoplasms 17 Breast Neoplasms 17 Carcinoma, Renal Cell 16 Urinary Bladder Neoplasms 13 Stomach Neoplasms 11 Neoplasm Metastasis 11 Solid Tumors 9 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Uterine Cervical Neoplasms 7 Lymphoma 7 Head and Neck Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Esophageal Neoplasms 5 Advanced Solid Tumor 5 Solid Tumor 4 Pancreatic Neoplasms 4 Liver Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Merkel Cell 4 Carcinoma 4 Multiple Myeloma 3

Interventions

Gemcitabine 22 Fluorouracil 12 Cisplatin 11 Carboplatin 11 Capecitabine 11 pembrolizumab 10 Pemetrexed 10 Paclitaxel 10 Oxaliplatin 10 130-nm albumin-bound paclitaxel 8 zolbetuximab 7 Leucovorin 7 trastuzumab deruxtecan 6 Ramucirumab 6 Albumin-Bound Paclitaxel 6 Nivolumab 4 Drug Therapy 4 Docetaxel 4 Bevacizumab 4 vandetanib 3 cemiplimab 3 Everolimus 3 EC145 3 tislelizumab 2 technetium 99m etarfolatide 2 spartalizumab 2 pralsetinib 2 osimertinib 2 nimotuzumab 2 napabucasin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05968326 2026-03-12

IMCODE003

Genentech, Inc.

Phase 2 Recruiting

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡